Download PDF
Am J Perinatol 2024; 41(S 01): e2759-e2766
DOI: 10.1055/s-0043-1775561
Original Article

Oral Contraceptive Pills Increase Circulating 25-Hydroxy-Vitamin D Concentrations in Women Who Are Lactating

Lori L. Huff 
1   Department of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, South Carolina
,
Elizabeth V. Schulz
2   Department of Pediatrics, Uniformed Services University, Bethesda, Maryland
,
Colby D. Richardson
3   Department of Pediatrics, Division of Neonatology, University of Rochester Medical Center, Rochester, New York
,
Myla D. Ebeling
1   Department of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, South Carolina
,
Judy R. Shary
1   Department of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, South Carolina
,
Bruce W. Hollis
1   Department of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, South Carolina
,
Carol L. Wagner
1   Department of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, South Carolina
› Author Affiliations Funding This research was supported by National Institutes of Health (grant nos: R01 HD047511, UL1RR029882, and UL1TR0000062).
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective This article aims to determine the association between maternal 25-hydroxy-vitamin D [25(OH)D] status and intake of hormonal oral contraceptive pills (OCPs) in women who are lactating.

Study Design Women who were exclusively breastfeeding participated in a randomized controlled trial assessing vitamin D supplementation at 400, 2,400, or 6,400 international unit (IU)/d from 1 month through 7 months postpartum. This observational, secondary analysis assessed whether OCPs were associated with maternal 25(OH)D concentrations in women who are lactating. Multivariate regression models were used to predict 25(OH)D concentrations and create parameter estimates for each variable.

Results In a bivariate analysis, the use of OCPs at 4 months was associated with increased serum 25(OH)D (p = 0.02). OCPs' use at 7 months was associated with a higher trend in 25(OH)D, but this finding was not statistically significant (p = 0.1). In a multivariate regression model at 4 months, independent positive predictors of 25(OH)D concentrations were the use of OCPs (p = 0.03) and treatment with vitamin D at 6,400 IU/d (p ≤ 0.0001). Negative predictors were Black (p = 0.001) and Hispanic (p = 0.0001) race and ethnicity, and body mass index (BMI) greater than 30 (p = 0.0002). The same pattern occurred at 7 months, with more southern latitude as a positive independent predictor (p = 0.04) of 25(OH)D concentration.

Conclusion The use of OCPs was associated with greater 25(OH)D in women who are lactating. Additionally, treatment with vitamin D at 6,400 IU/d and southern latitude was associated with greater 25(OH)D in women who are lactating. Black and Hispanic race and ethnicity, and BMI greater than 30, were independently associated with lower 25(OH)D in women who are lactating.

Key Points

  • The association of OCP with serum 25(OH)D concentrations during postpartum lactation is unknown.

  • OCPs' use was associated with higher 25(OH)D concentrations in postpartum women who are lactating.

  • Treatment with vitamin D and southern latitude was associated with greater 25(OH)D in women who are lactating.

  • Black and Hispanic, and BMI > 30 were associated with lower 25(OH)D in women who are lactating.

  • Practitioners can counsel women who are lactating on OCPs' use and the positive effects on their 25(OH)D status.

Keywords

vitamin D - breastfeeding - lactation - oral contraceptives

Authors' Contributions

Literature search, study design, supervision, writing—review and editing, and funding acquisition by C.L.W. Project administration, data collection, and data curation by J.R.S. Literature search, study design, methodology, supervision, funding acquisition, and writing—review and editing by B.W.H. Figures, data analysis, and writing—original draft by M.D.E. Literature search, figures, formal analysis, writing—original draft, and writing—review and editing by L.L.H and E.V.S. Literature search, formal analysis, writing—original draft, writing—review and editing by C.D.R. All authors approved the final article as submitted and agreed to be accountable for all aspects of the study.




Publication History

Received: 06 January 2023

Accepted: 17 August 2023

Article published online:
19 September 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Zapata LB, Murtaza S, Whiteman MK. et al. Contraceptive counseling and postpartum contraceptive use. Am J Obstet Gynecol 2015; 212 (02) 171.e1-171.e8
    CrossrefPubMedGoogle Scholar
  • 2 American College of Obstetricians and Gynecologists. Postpartum birth control. 2021 Updated November 2021. Accessed August 15, 2021 at: Acog.org/womens-health/faqs/postpartum-birth-control
    PubMedGoogle Scholar
  • 3 American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 495: Vitamin D: screening and supplementation during pregnancy. Obstet Gynecol 2011; 118 (01) 197-198
    CrossrefPubMedGoogle Scholar
  • 4 Caserta D, Ralli E, Matteucci E, Bordi G, Mallozzi M, Moscarini M. Combined oral contraceptives: health benefits beyond contraception. Panminerva Med 2014; 56 (03) 233-244
    PubMedGoogle Scholar
  • 5 Møller UK, Streym Sv, Jensen LT. et al. Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients 2013; 5 (09) 3470-3480
    CrossrefPubMedGoogle Scholar
  • 6 Pilz S, Obeid R, Schwetz V. et al. Hormonal contraceptive use is associated with higher total but unaltered free 25-hydroxyvitamin D serum concentrations. J Clin Endocrinol Metab 2018; 103 (06) 2385-2391
    CrossrefPubMedGoogle Scholar
  • 7 Hronek M, Poljaková G. [Effect of hormonal contraception on levels of vitamins in the body]. Ceska Gynekol 2004; 69 (05) 397-401
    PubMedGoogle Scholar
  • 8 Manson JE, Brannon PM, Rosen CJ, Taylor CL, Vitamin D. Vitamin D deficiency - is there really a pandemic?. N Engl J Med 2016; 375 (19) 1817-1820
    CrossrefPubMedGoogle Scholar
  • 9 Mansoor S, Habib A, Ghani F. et al. Prevalence and significance of vitamin D deficiency and insufficiency among apparently healthy adults. Clin Biochem 2010; 43 (18) 1431-1435
    CrossrefPubMedGoogle Scholar
  • 10 U.S. Department of Health and Human Services. Vitamin D. 2021 Accessed August 15, 2021 at: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
    PubMedGoogle Scholar
  • 11 Gellert S, Ströhle A, Hahn A. Breastfeeding woman are at higher risk of vitamin D deficiency than non-breastfeeding women - insights from the German VitaMinFemin study. Int Breastfeed J 2017; 12: 19
    CrossrefPubMedGoogle Scholar
  • 12 Wagner CL, Hulsey TC, Fanning D, Ebeling M, Hollis BW. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med 2006; 1 (02) 59-70
    CrossrefPubMedGoogle Scholar
  • 13 Wagner CL, Hollis BW. Early-life effects of vitamin D: a focus on pregnancy and lactation. Ann Nutr Metab 2020; 76 (Suppl. 02) 16-28
    CrossrefPubMedGoogle Scholar
  • 14 Holick MF, Binkley NC, Bischoff-Ferrari HA. et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96 (07) 1911-1930
    CrossrefPubMedGoogle Scholar
  • 15 Wagner CL, Greer FR. American Academy of Pediatrics Section on Breastfeeding, American Academy of Pediatrics Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008; 122 (05) 1142-1152
    CrossrefPubMedGoogle Scholar
  • 16 Hollis BW, Wagner CL, Howard CR. et al. Maternal versus infant vitamin D supplementation during lactation: a randomized controlled trial. Pediatrics 2015; 136 (04) 625-634
    CrossrefPubMedGoogle Scholar
  • 17 Wagner CL, Hulsey TC, Ebeling M. et al. Safety aspects of a randomized clinical trial of maternal and infant vitamin D supplementation by feeding type through 7 months postpartum. Breastfeed Med 2020; 15 (12) 765-775
    CrossrefPubMedGoogle Scholar
  • 18 Dawodu A, Salameh KM, Al-Janahi NS, Bener A, Elkum N. The effect of high-dose postpartum maternal vitamin D supplementation alone compared with maternal plus infant vitamin D supplementation in breastfeeding infants in a high-risk population. A randomized controlled trial. Nutrients 2019; 11 (07) 1632
    CrossrefPubMedGoogle Scholar
  • 19 Hollis BW, Wagner CL. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr 2004; 79 (05) 717-726
    CrossrefPubMedGoogle Scholar
  • 20 Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 2006; 9 (01) 84-93
    CrossrefPubMedGoogle Scholar
  • 21 Wyon MA, Wolman R, Nevill AM. et al. The influence of hormonal contraception on vitamin D supplementation on serum 25(OH)D3 status in premenopausal women: a prospective double-blind placebo random controlled trial. J Endocrinol Metab 2017; 7: 117-121
    CrossrefPubMedGoogle Scholar
  • 22 Harmon QE, Umbach DM, Baird DD. Use of estrogen-containing contraception is associated with increased concentrations of 25-hydroxy vitamin D. J Clin Endocrinol Metab 2016; 101 (09) 3370-3377
    CrossrefPubMedGoogle Scholar
  • 23 Ciebiera M, Włodarczyk M, Słabuszewska-Jóźwiak A, Ciebiera M, Nowicka G, Jakiel G. Vitamin D serum levels in women using contraception containing drospirenone - a preliminary study. Arch Med Sci 2019; 15 (02) 554-557
    CrossrefPubMedGoogle Scholar
  • 24 Rejnmark L, Lauridsen AL, Brot C. et al. Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest 2006; 66 (03) 227-238
    CrossrefPubMedGoogle Scholar
  • 25 Bikle DD, Schwartz J, Vitamin D. Vitamin D binding protein, total and free vitamin D levels in different physiological and pathophysiological conditions. Front Endocrinol (Lausanne) 2019; 10: 317
    CrossrefPubMedGoogle Scholar
  • 26 Dai Q, Zhu X, Manson JE. et al. Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial. Am J Clin Nutr 2018; 108 (06) 1249-1258
    CrossrefPubMedGoogle Scholar
  • 27 Uwitonze AM, Razzaque MS. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc 2018; 118 (03) 181-189
    CrossrefPubMedGoogle Scholar